Angelie Rivera-Rodríguez

Angelie Rivera-Rodríguez, Ph.D., currently serves as Scientist I in Cell Line and Cell Culture Process Development at Amgen since October 2023. Previously, Angelie was a Postdoctoral Scholar at Stanford University from July 2022 to September 2023, where project management and targeting lipid nanoparticles for CAR T cell development were key responsibilities. During a Ph.D. at the University of Florida from 2016 to 2022, Angelie led research on immune cell therapy and nanomedicine in oncology, notably pioneering magnetic nanoparticle applications for tracking T cells in brain cancer contexts. Earlier experiences include roles as IACUC Study Coordinator, Laboratory Manager and Safety Coordinator, and teaching positions, along with research assistant and intern roles across various institutions including AbbVie and the University of Wisconsin-Madison. Angelie holds a BS in Industrial Biotechnology from the University of Puerto Rico-Mayaguez.